Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer

PURPOSE: Cyclophosphamide/methotrexate/fluorouracil (CMF) is a proven adjuvant option for patients with early-stage breast cancer. Randomized trials with other regimens demonstrate that dose-dense (DD) scheduling can offer greater efficacy. We investigated the feasibility of administering CMF using...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Drullinsky, Pamela, Sugarman, Steven M., Fornier, Monica N., D’Andrea, Gabriella, Gilewski, Teresa, Lake, Diana, Traina, Tiffany, Wasserheit-Lieblich, Carolyn, Sklarin, Nancy, Atieh-Graham, Deena, Mills, Nancy, Troso-Sandoval, Tiffany, Seidman, Andrew D., Yuan, Jeffrey, Patel, Hamangi, Patil, Sujata, Norton, Larry, Hudis, Clifford
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3661192/
https://ncbi.nlm.nih.gov/pubmed/21147686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CBC.2010.n.057
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados